Vitamin B12 injections may be recommended for a wide range of people - not just those with a confirmed deficiency
GHK-Cu: The Copper Peptide That's Rewriting the Rules of Regeneration How a three-amino-acid sequence discovered in human blood became the Swiss Army knife of anti-aging medicine In the pantheon of anti-aging interventions, most compounds fall into one of two categories: the overhyped and underdelivered, or the promising but perpetually "five years away from clinical application." GHK-Cu, a copper-binding tripeptide that sounds like a military designation for classified equipment, occupies a refreshingly different space
TB-500 demonstrates similar but more localized effects, potentially due to its smaller molecular size and efficient tissue diffusion
To solve this dilemma, SHINE, a pathogenicity prediction tool, recruited protein language models, where protein secondary structure (coil), intrinsically disordered residues, and relative solvent accessibility were transformed into protein statistics (Fan et al., 2023)
Novo Nordisk submitted an NDA (new drug application) to the FDA on December 18, 2025, which is the formal step companies take when seeking approval for a medication to be marketed for public use
They might start with lower doses to avoid side effects
)
